Artwork Designer at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Strong experience in a graphical industry and pharmaceutical environment
Experience in artwork labeling and packaging design
Advanced professional certificate or BS degree in a graphical industry profession
A minimum of 3-5 years in artwork labeling and package design
Strong knowledge of the current Good Manufacturing Practice (cGMP) and its application in a pharmaceutical company
Proficiency in Adobe Creative Suite and other relevant graphical design software
Knowledge of GlobalVision and/or TVT and other relevant comparison software is a plus
Good knowledge of common MS Office software
Fluent in English; additional languages are a plus

Responsibilities

Create and revise artwork for printed packaging materials by utilizing provided regulatory text content, graphics, branding elements, and technical drawing structures
Perform technical verification of artwork to ensure compliance with packaging sites (internal or CMO) and/or print vendors
Distribute approved artwork to the packaging sites (internal or CMO) and/or print vendors for implementation
Review and approve vendor proofs provided by the packaging sites (internal or CMO) and/or print vendors
Establish color standards for complex graphics and other required elements
Record all activities in the BMS Artwork Management System
Complete assigned training to ensure compliance with BMS and global regulatory requirements
Review and complete all associated cGMP documentation
Provide partnership and support to Artwork Coordinator, Artwork Proofreader, regulatory markets packaging sites (internal or CMO), and print vendors

Skills

Packaging Artwork

Artwork Creation

Artwork Revision

Technical Verification

Regulatory Compliance

cGMP Documentation

Vendor Proof Approval

Color Standards

Graphics Design

Branding Elements

Technical Drawings

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free